Evidence map›Paper›PMID 31208362›Full record

ArticleBMC infectious diseases2019

Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional study.

Davaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, Delgerekh Baigal, Munkhzul Baatar, Nomin Enkhamgalan, Sumiya Erdenebaatar, Batbayar Ochirbat, Buyankhishig Burneebaatar, Enkhtamir Purevdorj and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Davaasambuu GanmaaHarvard T.H. Chan School of Public Health, Building 2, Room 211, 655 Huntington Ave, Boston, MA, 02115, USA. gdavaasa@hsph.harvard.edu.ORCID http://orcid.org/0000-0003-3388-8475
Polyna KhudyakovHarvard T.H. Chan School of Public Health, Building 2, Room 211, 655 Huntington Ave, Boston, MA, 02115, USA.
Uyanga BuyanjargalMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Delgerekh BaigalMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Munkhzul BaatarNational Center for Communicable Disease, Ulaanbaatar, Mongolia.
Nomin EnkhamgalanMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Sumiya ErdenebaatarMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Batbayar OchirbatMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Buyankhishig BurneebaatarMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Enkhtamir PurevdorjNational Center for Communicable Disease, Ulaanbaatar, Mongolia.
Yanjindulam PurevsurenNational Center for Communicable Disease, Ulaanbaatar, Mongolia.
Gantsetseg GarmaaMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar, Mongolia.
Erdenetuya GanbaatarMongolian National Health Sciences University, Ulaanbaatar, Mongolia.
Adrian R MartineauBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AB, London, UK.
National Center for Communicable Diseases · MNHarvard University · USQueen Mary University of London · GB

Funding

Trial of Vitamin D Supplementation to Prevent TB Infection in SchoolchildrenR01HL122624 · NHLBI · HARVARD SCHOOL OF PUBLIC HEALTH · PI DAVAASAMBUU, GANMAA · 2014 to 2018
$3.5M
NHLBI NIH HHS R01 HL122624NIH HHS 1R01HL122624-01
6 · The paper itself

Abstract

backgroundThere is controversy regarding the relative influence of 'exogenous' versus 'endogenous' factors on the risk of progression from latent tuberculosis infection to active tuberculosis (TB) disease in children.

methodsWe conducted a cross-sectional analysis to identify risk factors for active tuberculosis in QuantiFERON®-TB Gold (QFT-G)-positive children aged 6-13 years attending 18 schools in Ulaanbaatar, Mongolia. Children underwent clinical and radiological screening for active tuberculosis, and data relating to potential risk factors for disease progression were collected by questionnaire and determination of serum 25-hydroxyvitamin D (25[OH]D) concentrations. Risk ratios were calculated using generalized estimating equations with adjustment for potential confounders.

results129/938 (13.8%) QFT-positive children were diagnosed with active tuberculosis. Risk of active tuberculosis was independently associated with household exposure to pulmonary TB (adjusted risk ratio [aRR] 2.40, 95% CI 1.74 to 3.30, P < 0.001), month of sampling (adjusted risk ratio [aRR] for March-May vs. June-November 3.31, 95% CI 1.63 to 6.74, P < 0.001; aRR for December-February vs. June-November 2.53, 95% CI 1.23 to 5.19, P = 0.01) and active smoking by the child (aRR 5.23, 95% CI 2.70 to 10.12, P < 0.001). No statistically significant independent association was seen for age, sex, socio-economic factors, presence of a Bacillus Calmette-Guérin (BCG) scar, tobacco exposure or vitamin D status.

conclusionsHousehold exposure to active TB, winter or spring season and active smoking were independently associated with risk of active tuberculosis in QFT-positive children. Our findings highlight the potentially high yield of screening child household contacts of infectious index cases for active tuberculosis in low- and middle-income countries.

Indexed as

AdolescentChildCross-Sectional StudiesDisease ProgressionFemaleHematologic TestsHumansLatent TuberculosisMaleMass ScreeningMongoliaMycobacterium bovisOdds RatioRisk FactorsSmokingSurveys and Questionnaires25-hydroxyvitamin DVitamin DChildrenQuantiFERON®-TB goldRisk factorsTuberculosisVitamin D

Identifiers

PMID31208362
PMCPMC6580591
OpenAlexW2949406414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.